Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients.
Journal:
Cancer immunology, immunotherapy : CII
Published Date:
Jun 4, 2024
Abstract
BACKGROUND: The non-invasive biomarkers for predicting immunotherapy response are urgently needed to prevent both premature cessation of treatment and ineffective extension. This study aimed to construct a non-invasive model for predicting immunotherapy response, based on the integration of deep learning and habitat radiomics in patients with advanced non-small cell lung cancer (NSCLC).